Back to Search
FREDERIC MENDELSOHN, MD
MD
Neurology Physician
NPI: 1336247691Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
112676(NY)
Research & Publications (20)
Hyperperfusion syndrome following carotid artery stenting: the largest single-operator series to date.
PMID 19126924·J Invasive Cardiol·2009
8-other
Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase.
PMID 18716029·FASEB J·2008
7-preclinical
Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
PMID 18559703·Circulation·2008
2-rct
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
PMID 17452167·Am Heart J·2007
3-trial
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment.
PMID 16791287·Gene Ther·2006
3-trial
Oxytocinase/insulin-regulated aminopeptidase is distributed throughout the sheep, female reproductive tract and is regulated by oestrogen in the uterus.
PMID 15380925·Regul Pept·2004
7-preclinical
Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms.
PMID 15302130·Behav Brain Res·2004
4-observational
Design of the Del-1 for therapeutic angiogenesis trial (DELTA-1), a phase II multicenter, double-blind, placebo-controlled trial of VLTS-589 in subjects with intermittent claudication secondary to peripheral arterial disease.
PMID 15212720·Hum Gene Ther·2004
3-trial
Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats.
PMID 14980384·Neuroscience·2004
4-observational
Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
PMID 14504183·Circulation·2003
3-trial
Effect of fimbria-fornix lesion on 125I-angiotensin IV (Ang IV) binding in the guinea pig hippocampus.
PMID 12850565·Brain Res·2003
7-preclinical
Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
PMID 12796772·Am Heart J·2003
3-trial
The brain renin-angiotensin system: location and physiological roles.
PMID 12676175·Int J Biochem Cell Biol·2003
6-review
Angiotensin receptors: form and function and distribution.
PMID 12676163·Int J Biochem Cell Biol·2003
6-review
Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
PMID 12649370·J Pharmacol Exp Ther·2003
8-other
AT4 receptor is insulin-regulated membrane aminopeptidase: potential mechanisms of memory enhancement.
PMID 12591177·Trends Endocrinol Metab·2003
6-review
Organisation and functional role of the brain angiotensin system.
PMID 12428219·J Renin Angiotensin Aldosterone Syst·2002
6-review
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.
PMID 12086757·Lancet·2002
3-trial
Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.
PMID 11882622·Hypertension·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 650 HAWKINS AVE, SUITE 7
RONKONKOMA, NY 11779 - Phone
- (631) 737-0055
Quick Facts
- NPI
- 1336247691
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile